UnitedHealth (UNH) reported Q4 FY 2021 earnings of $4.48 per share (versus $2.52 per share in Q4 FY 2020), beating analysts’ consensus estimate of $4.31 per share.
The company’s quarterly revenues amounted to $73.743 bln (+12.6% y/y), beating analysts’ consensus estimate of $72.858 bln.
The company also reaffirmed guidance for FY 2022, foreseeing EPS of $21.10-21.60 versus analysts’ consensus estimate of $21.65 and revenues of $317-320 bln versus analysts’ consensus estimate of $317.55 bln.
UNH rose to $462.14 (+0.25%) in pre-market trading.
